Abstract
Complement receptors type 1 and 2 (CR1 (CD35)/CR2 (CD21)) are known to enhance the adaptive immune response. In mice, CR1/CR2 are expressed on B cells, follicular dendritic cells, and activated granulocytes. Recently, we showed that a subset of CD44high and CD62Llow T cells also expresses CR1 and CR2. We now report that CR1/CR2 are detectable on both CD4+ and CD8+ subsets of T cells. Lipopolysaccharide (LPS) from Gram-negative bacteria causes polyclonal activation of B cells and stimulation of macrophages and other antigen-presenting cells. We further demonstrate that LPS induced marked up-regulation of CD25 and CD69 on T cells from CR1/CR2 sufficient (Cr+/+), but significantly lower up-regulation on T cells from CR1/CR2 deficient (Cr-/-) mice. These findings point to a novel mechanism by which CR1/CR2 modulates the activation of T cells by LPS.
Publication types
-
Research Support, Non-U.S. Gov't
-
Research Support, U.S. Gov't, P.H.S.
MeSH terms
-
Animals
-
Antigens, CD / immunology
-
Antigens, Differentiation, T-Lymphocyte / immunology
-
B-Lymphocytes / immunology
-
CD4-Positive T-Lymphocytes / immunology
-
CD8-Positive T-Lymphocytes / immunology
-
Cell Separation
-
Cells, Cultured
-
Flow Cytometry
-
Lectins, C-Type
-
Lipopolysaccharides / pharmacology*
-
Lymphocyte Activation / drug effects*
-
Macrophages / immunology
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Receptors, Complement / immunology*
-
Receptors, Complement 3b / immunology
-
Receptors, Complement 3d / immunology
-
Receptors, Interleukin-2 / immunology
-
T-Lymphocytes / immunology*
Substances
-
Antigens, CD
-
Antigens, Differentiation, T-Lymphocyte
-
CD69 antigen
-
Lectins, C-Type
-
Lipopolysaccharides
-
Receptors, Complement
-
Receptors, Complement 3b
-
Receptors, Complement 3d
-
Receptors, Interleukin-2